
ADC Therapy Brochure
In the race to develop next-generation ADCs—targetingTROP2, HER2, EGFR, and beyond—the biggest barriersaren’t always biological. Hidden pitfalls like inconsistenttarget expression, unclear mechanisms of action, andoff-tumor

In the race to develop next-generation ADCs—targetingTROP2, HER2, EGFR, and beyond—the biggest barriersaren’t always biological. Hidden pitfalls like inconsistenttarget expression, unclear mechanisms of action, andoff-tumor

Discovery’s mIF services makes it easy to visualize and analyze complex tissue samples, taking your spatial biology research to the next level. We deliver multidimensional

ADME research is increasingly shifting toward more human-relevant in vitro models that capture the complexity of liver biology. While traditional 2D hepatocyte cultures are well-established

Advance your gene therapy research with Gentest® Cryopreserved Mouse Hepatocytes derived from CD-1 and C57BL/6 strains. These high-quality cells deliver reliable plateability, high cellular viability,

In vitro induction studies are valuable predictors of in vivo drug-drug interactions. Gentest® ADME Research Services utilizes high quality, highly characterized Gentest® human and animal

Discovery’s mass spectrometry-based proteomics service enables highly accurate and sensitive identification and quantification of proteins without the need for antibodies. It has broad applications in

First At-Scale Deployment of AI Technologies into Leading Commercial Biobank. PathAI, a leading provider of AI-powered technology for pathology, partners with Discovery Life Sciences to


